AU2068599A - Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation - Google Patents

Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation

Info

Publication number: AU2068599A
Authority: AU; Australia
Prior art keywords: polypeptides; formulations; dna coding; factor xii; inhibiting factor
Prior art date: 1998-01-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU20685/99A

Inventor

Sarah Finney

Lisa Seale

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BIO-DISCOVERY Ltd

Original Assignee

BIO DISCOVERY Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-16

Filing date

1999-01-15

Publication date

1999-08-02

1999-01-15 Application filed by BIO DISCOVERY Ltd filed Critical BIO DISCOVERY Ltd

1999-08-02 Publication of AU2068599A publication Critical patent/AU2068599A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Immunology (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU20685/99A 1998-01-16 1999-01-15 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation Abandoned AU2068599A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9800817		1998-01-16
GBGB9800817.0A GB9800817D0 (en)	1998-01-16	1998-01-16	Serine protease inhibitors
PCT/GB1999/000147 WO1999036439A1 (en)	1998-01-16	1999-01-15	Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation

Publications (1)

Publication Number	Publication Date
AU2068599A true AU2068599A (en)	1999-08-02

Family

ID=10825322

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU20685/99A Abandoned AU2068599A (en)	1998-01-16	1999-01-15	Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation

Country Status (6)

Country	Link
EP (1)	EP1045862A1 (en)
JP (1)	JP2002508953A (en)
AU (1)	AU2068599A (en)
CA (1)	CA2318358A1 (en)
GB (1)	GB9800817D0 (en)
WO (1)	WO1999036439A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9930659D0 (en) *	1999-12-24	2000-02-16	Bio Discovery Ltd	Inhibitors of complement activation
AU2001282857A1 (en) *	2000-06-21	2002-01-02	Zymogenetics Inc.	Peptide and polypeptide inhibitors of complement c1s
CN1373218A (en) *	2001-02-28	2002-10-09	中国医学科学院阜外心血管病医院	Inflammatory suppressor factor Fwa 116
WO2006066878A1 (en)	2004-12-23	2006-06-29	Csl Behring Gmbh	Prevention of thrombus formation and/or stabilization
KR101954052B1 (en) *	2011-03-09	2019-03-06	체에스엘 베링 게엠베하	Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
EP2497489A1 (en)	2011-03-09	2012-09-12	CSL Behring GmbH	Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
EP2623110A1 (en) *	2012-01-31	2013-08-07	CSL Behring GmbH	Factor XII inhibitors for the treatment of neurological inflammatory disorders
WO2014135694A1 (en)	2013-03-08	2014-09-12	Csl Behring Ag	Treatment and prevention of remote ischemia-reperfusion injury
JP2017501968A (en) *	2013-06-28	2017-01-19	ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー	Combination therapy using factor XII inhibitor and C1-inhibitor
WO2015054569A1 (en) *	2013-10-10	2015-04-16	Viropharma Holdings Limited	Methods of inhibiting the alternative pathway of complement immune system activation and compositions used therein
US11505619B2 (en)	2017-12-15	2022-11-22	Csl Limited	Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0333356A3 (en) *	1988-03-04	1990-12-19	Biogen, Inc.	Hirudin peptides
EP0719334A1 (en) *	1993-09-14	1996-07-03	Genentech, Inc.	Pharmaceutical compositions containing ecotin and homologs thereof
US5866402A (en) *	1995-05-05	1999-02-02	Chiron Corporation	Chimeric MCP and DAF proteins with cell surface localizing domain

1998
- 1998-01-16 GB GBGB9800817.0A patent/GB9800817D0/en not_active Ceased
1999
- 1999-01-15 CA CA002318358A patent/CA2318358A1/en not_active Abandoned
- 1999-01-15 JP JP2000540154A patent/JP2002508953A/en active Pending
- 1999-01-15 AU AU20685/99A patent/AU2068599A/en not_active Abandoned
- 1999-01-15 EP EP99901059A patent/EP1045862A1/en not_active Withdrawn
- 1999-01-15 WO PCT/GB1999/000147 patent/WO1999036439A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2002508953A (en)	2002-03-26
CA2318358A1 (en)	1999-07-22
WO1999036439A1 (en)	1999-07-22
EP1045862A1 (en)	2000-10-25
GB9800817D0 (en)	1998-03-11

Publication	Publication Date	Title
HUP0102535A3 (en)	2005-12-28	Cd19xcd3 specific polypeptides and uses thereof
AU5850798A (en)	1998-08-26	Polynucleotides encoding proexendin, and methods and uses thereof
AU1220001A (en)	2001-04-30	Novel proteins and polynucleotides encoding them
HUP0102302A3 (en)	2003-03-28	Gene coding for heliomicine and use thereof
AU2068599A (en)	1999-08-02	Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
HUP0104825A3 (en)	2008-04-28	Genes and proteins, and their use
AU2001264852A1 (en)	2001-12-03	Lactobacillusbeta -glucuronidase and dna encoding the same
AU5475199A (en)	2000-03-06	Human chordin-related proteins and polynucleotides encoding them
ZA9810625B (en)	2000-05-22	Benzylidenepyrazolones, their preparation and use.
AU1101099A (en)	1999-05-10	Dna encoding a gababr2 polypeptide and uses thereof
AU4273099A (en)	2000-01-10	Polypeptides, polynucleotides and uses thereof
IL137493A0 (en)	2001-07-24	Svph3-13 and spvh3-17 dna and polypeptides
HUP0201022A2 (en)	2002-08-28	Outer surface proteins, their genes, and their use
AU1926699A (en)	1999-07-05	Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
AU2001241446A1 (en)	2001-08-14	Human transporter proteins and polynucleotides encoding the same
GB9824357D0 (en)	1998-12-30	Protein and DNA coding therefor
AU2001275337A1 (en)	2001-12-17	Novel human transporter proteins and polynucleotides encoding the same
AU2076701A (en)	2001-06-18	Novel human transporter protein and polynucleotides encoding the same
AU9362801A (en)	2002-01-08	A novel polypeptide, a human protein 10 containing a group and the polynucleotide encoding the polypeptide
AU3866799A (en)	1999-11-23	Cytoplasmic antiproteinase-3 coding sequence in gene therapy
AU2002233265A1 (en)	2002-06-24	Human caplain proteins and polynucleotides coding therefor
AU4392599A (en)	2000-01-10	Human glycoprotease-like proteins and dnas encoding these proteins
AU1485301A (en)	2001-06-06	Human membrane proteins and polynucleotides encoding the same
AU2001247283A1 (en)	2001-09-17	Human transporter proteins and polynucleotides encoding the same
AU2001241673A1 (en)	2001-09-03	Novel human regulatory protein and polynucleotides encoding the same

Legal Events

Date	Code	Title	Description
2000-09-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase